Hyaluronic%252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520acid

# Hyaluronic acid ## Overview Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in various connective tissues. It acts as a lubricant and shock absorber. Various formulations exist for different routes of administration and indications. ## Primary Indications * **Intra-articular injection:** Osteoarthritis (knee, hip), viscosupplementation. * **Ophthalmic surgery:** Viscoelastic agent to maintain anterior chamber space during cataract and other intraocular surgeries. * **Wound healing/Dermatology:** Topical formulations for skin hydration and wound care. * **Intranasal:** Management of nasal dryness and crusting. ## Adult Dosing * **Intra-articular (Knee):** Varies by product. Common regimens include: * Single injection of 20 mg/2 mL (10 mg/mL) once. * Weekly injections for 3-5 weeks, typically 20 mg/2 mL (10 mg/mL) per injection. * Maximum frequency typically 6-month intervals. * **Intra-articular (Hip):** Varies by product, often single injection of 20-30 mg/2 mL (10-15 mg/mL). * **Ophthalmic surgery:** Typically 0.1-3.0 mL administered intraocularly as needed per procedure. * **Topical (Dermatology/Wound):** Varies significantly by product formulation (creams, gels, solutions). Follow specific product instructions. * **Intranasal:** Varies by product. Commonly administered as a spray or drops once to several times daily. ## Pediatric Dosing Dosing for hyaluronic acid in pediatric patients is generally not established for intra-articular or ophthalmic indications and should be based on specific product labeling or expert consultation. Topical and intranasal formulations may have specific pediatric recommendations; consult product monographs. ## Dose Adjustments No dose adjustments are typically required for hepatic or renal impairment. ## Contraindications * Known hypersensitivity to hyaluronic acid or any component of the formulation. * Active joint infection or severe skin infection over the injection site. * Intra-articular injections are contraindicated in patients with severe hemarthrosis. ## Adverse Effects * **Intra-articular:** Transient joint pain, swelling, stiffness, localized pain at injection site. Rarely, arthralgia, arthritis, joint effusion. * **Ophthalmic:** Transient intraocular pressure elevation, inflammation, edema. * **Topical:** Generally well-tolerated. May include mild local irritation. * **Intranasal:** Nasal irritation, discomfort. ## Key Drug Interactions * **Intra-articular:** Concurrent use of intra-articular corticosteroids may theoretically increase the risk of infection or cartilage breakdown, although clinical significance is uncertain. Avoid concurrent use of other intra-articular injections. * Other drug interactions are not well-established for most formulations. ## Monitoring * **Intra-articular:** Monitor for signs of infection (fever, chills, increased pain, swelling) at the injection site. Assess for symptom relief and duration of effect. * **Ophthalmic:** Monitor intraocular pressure post-operatively. * **Topical/Intranasal:** Monitor for local skin or nasal irritation. ## Clinical Pearls * Hyaluronic acid is a viscoelastic solution used for lubrication and shock absorption. * For intra-articular use, efficacy and duration of benefit can vary significantly between products and individuals. * Ensure the injection site is clean and dry prior to intra-articular administration. * Advise patients to avoid strenuous activity or prolonged weight-bearing on the injected joint for 24-48 hours. * Topical formulations are often used for moisturizing and supporting skin barrier function. --- *Disclaimer: This information is intended for clinical professionals and is not exhaustive. Always consult the current official prescribing information and relevant literature before making clinical decisions.*